-
Domestic vascular interventional surgical robot track ushered in "golden time"
Time of Update: 2022-11-04
A number of technical barriers need to be broken through Based on significant clinical advantages, vascular interventional surgical robots have gradually become a hot track, and their development direction is diversified.
-
The sales of quick-acting heart-saving pills exceeded 1 billion, and Darentang's performance was promising!
Time of Update: 2022-11-04
pharmacy In this issue, the big data platform of TCM industry of Tiandi Yuntu makes a brief analysis of the cost pressure of traditional Chinese medicine raw materials of enterprises from the perspective of raw materials involved in quick-acting heart-saving pills.
-
New drug for atopic dermatitis (AD)! IL-13 inhibitor lebrikizumab enters review in the EU: long-lasting removal of skin lesions, relieves itching!
Time of Update: 2022-11-04
Results showed that patients who received lebrikizumab (every 2 weeks) during the 16-week induction phase of two monotherapy trials (ADvocate 1 and 2) and achieved a clinical response at week 16 continued to receive lebrikizumab during the maintenance phase for up to one year, achieving durable lesion clearance and itching relief.
-
More than 460 pharmaceutical companies disclosed the third quarterly report, and the net profit of this high-gloss enterprise exceeded 10 billion!
Time of Update: 2022-11-04
Among the 23 listed companies with net profit exceeding 2 billion yuan, 17 achieved year-on-year growth, including WuXi AppTec, Wantai Biologics, Mentor Biologics, Anxu Biologics, Kelleying, Renfu Pharmaceutical, BGI, etc.
-
The innovation of traditional Chinese medicine has accelerated, and many pharmaceutical companies have achieved significant growth in performance in the third quarter
Time of Update: 2022-11-04
In addition, Wellcome Pharmaceutical also said that it attaches great importance to the research and development and innovation of traditional Chinese medicine, and achieved operating income of 474 million yuan and net profit attributable to the parent of 94 million yuan in the first three quarters of this year, a year-on-year increase of 1.
-
The National Medical Insurance Administration announced that the two pharmaceutical companies were assessed as "serious" untrustworthy
Time of Update: 2022-11-04
, Ltd. gave kickbacks or improper benefits to relevant personnel of a number of medical institutions in order to obtain additional trading opportunities, competitive advantages and sales quantities for the traditional Chinese medicine pieces it operated, equivalent to a total of more than 1.
-
CXO's performance is clearly differentiated, and the first three quarters of the head are outstanding
Time of Update: 2022-11-04
Recently, the first three quarters of listed companies are disclosed period, in the pharmaceutical industry, the CXO (pharmaceutical outsourcing services) companies in the subdivision track have obvious performance differentiation, including WuXi AppTec, Porton, Clarion, Zhaoyan New Drug, Jiuzhou Pharmaceutical, Sunshine Novo and many other leading companies in the first three quarters performance are very eye-catching.
-
The 15 provinces have not been evaluated drug procurement alliance is coming! Price accounts for only 40% of the factor
Time of Update: 2022-11-04
, the score is not cumulative, and the highest score shall prevail;product quality Supply security index (13 points): different points are assigned according to the distribution rate index; Comprehensive indicators (18 points): including several indicators such as untrustworthy recruitment records, national procurement selection, market share, coverage of medical institutions, and industry rankings, with different scores.
-
The pharmaceutical circulation industry will take the "Internet +" express train, and the market size will exceed 370 billion yuan
Time of Update: 2022-11-04
js?cdnversion='+~(-new Date()/36e5)];According to the user type and distribution channel, pharmaceutical e-commerce can be divided into three types: B2B, B2C and O2O, of which B2B serves each B-end of the pharmaceutical industry and occupies the main position of pharmaceutical e-commerce transactions.
-
The "debut" of the SERC Summit Forum, "Carbon Visit" Petrochemical Wastewater Treatment on November 8th!
Time of Update: 2022-11-04
【Pharmaceutical Network Conference Forum】Pass on! The 2022 FEC-Autumn Fair will start online on November 8, and on the same day, as an important part of the online conference of the FEC Summit Forum,
-
Anti-ED "miracle drug" broke 4 billion for the first time! Baiyun Mountain is firmly in the lead, and Qilu has soared
Time of Update: 2022-11-04
Men's Health Day is October 28. Erectile dysfunction (ED) is one of the common diseases affecting men's health, Intranet data shows that in recent years, the anti-ED drug market has expanded year by
-
Domestic pharmaceutical companies are accelerating the exploration of "Internet + traditional Chinese medicine" innovative diagnosis and treatment mode!
Time of Update: 2022-11-04
js?cdnversion='+~(-new Date()/36e5)];According to the relevant person in charge, Meituan Buy Medicine Online Consultation TCM Department has cooperated with more than 100 TCM physicians from Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences, Guanganmen Hospital and other TCM hospitals, and will cooperate with more well-known TCM physicians across the country in the future to provide users with online TCM consultation services.
-
Under the pressure of centralized procurement and price reduction, more than 2,800 proprietary Chinese medicines have been suspended!
Time of Update: 2022-11-04
js?cdnversion='+~(-new Date()/36e5)];Recently, the Hainan Provincial Public Resources Trading Service Center issued the "Notice on the Suspension of Trading of Some Network-Linked Products", which shows that 2,810 proprietary Chinese medicine products from 786 enterprises have suspended trading, and the suspended varieties include Huoxiang Zhengqi Water, Banlan Root Granules, Liuwei Dihuang Pill, Bezoar Detoxification Tablets, etc.
-
The first drug treatment for vitiligo! Opzelura (ruxolitinib) cream: significantly improves facial & systemic skin lesions repigmentation!
Time of Update: 2022-11-04
The data showed that the two phase 3 trials (TRuE-V1, TRuE-V2) of the project met both the primary and key secondary endpoints: after 24 weeks of treatment, patients in the Opzelura cream treatment group had a significant improvement in facial and systemic skin lesion repigmentation compared with the excipient-cream treatment group.
-
Hong Kong's first International Healthcare Week will be held from 1 November
Time of Update: 2022-11-04
(End) The Hong Kong Trade Development Council (HKTDC) held a press conference in Hong Kong on the 31st, saying that the first "International Health Week" initiated by the agency will be held in Hong Kong from November 1 to 15.
-
Shandong, Shanxi and other places have clarified the implementation time of the seventh batch of national centralized procurement of drugs
Time of Update: 2022-11-04
For example, Shandong Province clarified in the notice the "timetable" for the landing of the results of the seventh batch of national centralized procurement drugs: before November 13, 2022, the main supplier enterprises and the backup supply enterprises will respectively hang the selected drugs and spare drugs on the provincial centralized procurement platform for drugs and equipment according to the selected price, so that medical institutions can purchase an appropriate amount of selected drugs for stocking.
-
The upgrading trend of the pharmaceutical equipment industry will be more automated, digital and intelligent
Time of Update: 2022-11-04
In November of the same year, the Notice on Promoting the High-quality Development of the API Industry Implementation Plan was issued, requiring the promotion of cross-field resource sharing and cooperation, strengthening the integration and cooperation between bioengineering, fine chemicals, hazardous waste disposal, pharmaceutical equipment and API enterprises, and improving the modernization level of the industrial chain.
-
State Food and Drug Administration: Ensure the quality and safety of medical device transportation and storage, and promote the traceability of the whole process
Time of Update: 2022-11-04
The Appendix puts forward specific requirements for enterprises specializing in the transportation and storage of medical devices from the aspects of establishment and improvement of quality management system, institutions and personnel, facilities and equipment, computer information systems and quality responsibilities.
-
The State Food and Drug Administration issued an announcement on the revision of drug inserts such as Banlangen injection
Time of Update: 2022-11-04
2. Drug marketing authorization holders shall conduct in-depth research on the mechanism of new adverse reactions, take effective measures to publicize and train on drug use and safety issues, and guide physicians, pharmacists and patients in rational drug use.
-
State Food and Drug Administration: Revise the instructions for drugs such as Banlangen injection
Time of Update: 2022-11-04
According to the results of the adverse drug reaction assessment, in order to further protect the safety of public drug use, the State Medical Products Administration decided to uniformly revise the warning words and [adverse reactions], [contraindications] and [precautions] in the instructions of astragalus polysaccharides for injection, sodium chloride injection and banlangen injection.
